Safety and Efficacy of Inactivated Flu Vaccine Delivered via Microneedle Patch
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Safety, Immunogenicity, and Acceptability of Inactivated Influenza Vaccine Delivered by Microneedle Patch (TIV-MNP 2015): A Randomised, Partly Blinded, Placebo-Controlled, Phase 1 Trial
Lancet 2017 Jun 27;[EPub Ahead of Print], NG Rouphael, M Paine, R Mosley, S Henry, DV McAllister, H Kalluri, W Pewin, PM Frew, T Yu, NJ Thornburg, S Kabbani, L Lai, EV Vassilieva, I Skountzou, RW Compans, MJ Mulligan, MR PrausnitzFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.